Sourced, dated facts on biotech and pharma companies, deals and Taiwan biotech filings.
Score is being calculated.
Daily closing price moves of Taiwan-listed, OTC and emerging biotech and medical stocks, each linked to same-day material announcements and related Drugnews articles. Official exchange data; facts only.
| Name | Required | Description | Default |
|---|---|---|---|
| date | No | Trading date in YYYY-MM-DD; omit for the latest board. | |
| limit | No | ||
| direction | No | all |
Returns the machine-readable twin of one article: title, date, summary, key points (three quotable conclusions), fact table (value + source + as-of date), references, section headings and image URLs. Pass the article URL, or '-' (e.g. 2026-10-18-immunitybio-anktiva-papillary-early-approval).
| Name | Required | Description | Default |
|---|---|---|---|
| url | Yes | Article URL or <date>-<slug> |
Structured profile of a biotech / pharma / tech company: verified facts with sources and dates (products, milestones, capacity, financials, partnerships), plus the company's own responses to negative events. Data is provided by the company and verified by Drugnews on verified_at; negative events are kept and the company's response is listed alongside. Use the company name, alias or ticker.
| Name | Required | Description | Default |
|---|---|---|---|
| name | Yes | Company name (Chinese or English), alias or stock ticker, e.g. '台康生技', 'EirGenix', '6589' |
Returns dated, sourced facts (number, unit, as-of date, source URL, article URL) collected across Drugnews articles that match the query. Best for 'what are the numbers on X' questions; every fact carries the public source it came from.
| Name | Required | Description | Default |
|---|---|---|---|
| limit | No | ||
| query | Yes | Company, drug or topic (e.g. 'ImmunityBio', 'UroGen', 'CDMO 台康') |
The newest Drugnews articles with title, URL, date, summary and key points. Default: 10 Chinese articles.
| Name | Required | Description | Default |
|---|---|---|---|
| lang | No | zh-Hant | |
| limit | No |
Material announcements (重大訊息) of Taiwan-listed, OTC and emerging biotech/medical companies, collected hourly from the Market Observation Post System (公開資訊觀測站): subject, full text, clause, fact date, time. Primary source, no interpretation. Filter by company (name or ticker), keywords and days. Cite the company, date and subject (cite_as).
| Name | Required | Description | Default |
|---|---|---|---|
| days | No | ||
| limit | No | ||
| query | No | Keywords in subject or text, e.g. '授權', 'FDA', '臨床' (optional) | |
| company | No | Company name or ticker, e.g. '台康生技' or '6589' (optional) |
Full-text search over Drugnews｜藥時事 biotech and pharma business analysis (Traditional Chinese and English). Returns title, canonical URL, date, summary, key points and the .json / .md twins. Use Chinese or English company, drug or topic names.
| Name | Required | Description | Default |
|---|---|---|---|
| lang | No | any | |
| limit | No | ||
| query | Yes | Keywords: company, drug, indication, deal, topic (e.g. 'Celltrion 生物相似藥', 'Anktiva bladder cancer') |
Headlines from Drugnews partner publications (e.g. 環球生技) with link, date, a one-line Drugnews summary and sourced facts. Full text stays on the publisher's site; cite the publisher and link.
| Name | Required | Description | Default |
|---|---|---|---|
| limit | No | ||
| query | Yes | Keywords: company, drug, topic | |
| publisher | No | Limit to one publisher name (optional) |
Recent tool additions, removals, and schema changes observed during successful MCP inspections.
biotech_moversget_articleget_companyget_factslatest_articleslatest_filingssearch_articlessearch_partnersChina Pharma MCP — China-to-Western biotech licensing deals, from SEC filings.
Biotech News MCP — aggregated biotech & pharma industry news: FDA approvals, clinical readouts…
FDA drug approvals, 510(k) device clearances, recalls and adverse-event reports.
Biotech intelligence for AI agents: drugs, targets, diagnostics, PoS estimates, and writeups.
Add one secure layer between your agents and this server.
